,uuid,title,publisher,link,providerPublishTime,type
0,3c45aa24-0be8-39cb-9fc4-ae91bc71a73b,What Kind Of Shareholders Hold The Majority In AbbVie Inc.'s (NYSE:ABBV) Shares?,Simply Wall St.,https://finance.yahoo.com/news/kind-shareholders-hold-majority-abbvie-143608645.html,1653662168,STORY
1,b1eedb1d-8551-3bc0-aba1-3b4e5cc28b6a,The Lancet Publishes Results from Phase 3 Induction and Maintenance Programs Evaluating Upadacitinib (RINVOQ®) in Ulcerative Colitis,PR Newswire,https://finance.yahoo.com/news/lancet-publishes-results-phase-3-071500315.html,1653635700,STORY
2,9d2fda01-507a-3e35-9a14-0c01d2665d9a,The Lancet Publishes Results from Phase 3 Induction and Maintenance Programs Evaluating Risankizumab (SKYRIZI®) in Crohn's Disease,PR Newswire,https://finance.yahoo.com/news/lancet-publishes-results-phase-3-070000423.html,1653634800,STORY
3,077348f9-154c-30c0-827c-63f53b34702c,AbbVie's Correction Appears to Be Over: Here's Where the Stock Could Be Headed,TheStreet.com,https://finance.yahoo.com/m/077348f9-154c-30c0-827c-63f53b34702c/abbvie%27s-correction-appears.html,1653589140,STORY
4,2ba77cb7-8b04-3d5a-b01c-065ea14eaacd,Amgen (AMGN) Ahead of Industry This Year So Far: What's Next?,Zacks,https://finance.yahoo.com/news/amgen-amgn-ahead-industry-far-115111980.html,1653565871,STORY
5,679f570f-a870-3ef1-a644-6eaeeb20231f,3 Healthcare Stocks You Can Buy and Hold for the Next Decade,Motley Fool,https://finance.yahoo.com/m/679f570f-a870-3ef1-a644-6eaeeb20231f/3-healthcare-stocks-you-can.html,1653559200,STORY
6,cc8420fe-01f8-3e0b-85b4-85ff830fff37,Is AbbVie Stock A Buy As Humira Biosimilar Rivals Loom?,Investor's Business Daily,https://finance.yahoo.com/m/cc8420fe-01f8-3e0b-85b4-85ff830fff37/is-abbvie-stock-a-buy-as.html,1653499875,STORY
7,148c0a67-9152-3dc6-8dcd-6e0216574877,SpringWorks (SWTX) Down Despite Desmoid Tumors Study Meeting Goal,Zacks,https://finance.yahoo.com/news/springworks-swtx-down-despite-desmoid-160504171.html,1653494704,STORY
